Elizabeth L Hougen Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Elizabeth L Hougen has an estimated net worth of at least $12.7 million*, as of Oct. 29, 2025. They own 132,881 shares of IONS stock. They have sold 101,270 shares of IONS stock since 2021, for an estimated $4.5 million.
Elizabeth L Hougen $IONS SEC Form 4 Insider Trading
Elizabeth L Hougen has filed a total of 9 insider trades in $IONS since 2021. Their most recent trade was a sale of 6,988 shares, made on Jan 30, 2026. Their largest trade was a sale of 49,800 shares, made on Sep 30, 2025. We estimate that they now own 132,881 shares of $IONS, worth an estimated $8.1 million.
Insider Trading at $IONS
There have been a total of 259 insider trades reported at $IONS since 2021, with 20,000 shares purchased and 2.6 million shares sold. The most active insider traders in $IONS stock have been Brett P Monia, Eric Swayze, and Patrick R. O'Neil. The most recent trade was a sale of 6,207 shares reported by Eric Swayze (EVP Research), made on Feb 13, 2026.
History of Insider Stock Trades by Elizabeth L Hougen
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
IONS
|
Sale | 6,988 | Jan 30, 2026 | Feb. 2, 2026, 9:51 p.m. |
IONS
|
Sale | 12,922 | Jan 16, 2026 | Jan. 20, 2026, 9:18 p.m. |
IONS
|
Sale | 49,800 | Sep 30, 2025 | Oct. 1, 2025, 4:55 p.m. |
IONS
|
Sale | 1,523 | Jan 31, 2025 | Feb. 3, 2025, 8:26 p.m. |
IONS
|
Sale | 8,870 | Jan 16, 2025 | Jan. 17, 2025, 8:40 p.m. |
IONS
|
Sale | 2,125 | Feb 02, 2024 | Feb. 2, 2024, 8:55 p.m. |
IONS
|
Sale | 8,683 | Jan 17, 2024 | Jan. 18, 2024, 6:48 p.m. |
IONS
|
Sale | 2,079 | Feb 06, 2023 | Feb. 7, 2023, 6:36 p.m. |
IONS
|
Sale | 8,280 | Jan 18, 2023 | Jan. 19, 2023, 9:19 p.m. |
$IONS Executives and Stock Owners with Insider Trades
-
Brett P Monia, Chief Executive Officer
-
Eric Swayze, EVP Research
-
Patrick R. O'Neil, EVP CLO & General Counsel
-
Richard S Geary, EVP, Chief Development Officer
-
C Frank Bennett, EVP, Chief Scientific Officer
-
Joseph Baroldi, EVP, Chief Business Officer
-
Eugene Schneider, EVP, Chf Clinical Develop Ofcr
-
Shannon L. Devers, EVP, Chief Human Resources Ofc
-
Brian Birchler, EVP, Corp and Development Ops
-
Elizabeth L Hougen, EVP, Finance & CFO
-
Onaiza Cadoret-Manier, EVP, Chf GL Pdt Str & Oper Ofc
-
Kyle Jenne, EVP, Chf GL Pdt Str Ofcr
-
Holly B. Kordasiewicz, EVP, Chief Development Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.